| Large-scale design of robust genetic circuits with multiple inputs and outputs for mammalian cells BH Weinberg, NTH Pham, LD Caraballo, T Lozanoski, A Engel, S Bhatia, ... Nature biotechnology 35 (5), 453-462, 2017 | 252 | 2017 |
| High-performance chemical-and light-inducible recombinases in mammalian cells and mice BH Weinberg, JH Cho, Y Agarwal, NTH Pham, LD Caraballo, M Walkosz, ... Nature communications 10 (1), 4845, 2019 | 53 | 2019 |
| Inducible gene switches with memory in human T cells for cellular immunotherapy D Chakravarti, LD Caraballo, BH Weinberg, WW Wong ACS synthetic biology 8 (8), 1744-1754, 2019 | 22 | 2019 |
| Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells L Cai, LD Caraballo Galva, Y Peng, X Luo, W Zhu, Y Yao, Y Ji, Y He Frontiers in immunology 11, 607, 2020 | 21 | 2020 |
| Engineering T cells for immunotherapy of primary human hepatocellular carcinoma LDC Galva, L Cai, Y Shao, Y He Journal of genetics and genomics 47 (1), 1-15, 2020 | 15 | 2020 |
| Novel low‐avidity glypican‐3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC LDC Galva, X Jiang, MS Hussein, H Zhang, R Mao, P Brody, Y Peng, ... Hepatology 76 (2), 330-344, 2022 | 14* | 2022 |
| Meeting measurement precision requirements for effective engineering of genetic regulatory networks J Beal, B Teague, JT Sexton, S Castillo-Hair, NA DeLateur, M Samineni, ... ACS Synthetic Biology 11 (3), 1196-1207, 2022 | 9 | 2022 |
| A single-layer platform for boolean logic and arithmetic through dna excision in mammalian cells BH Weinberg, NTH Pham, LD Caraballo, T Lozanoski, A Engel, S Bhatia, ... Nature biotechnology 35 (5), 453, 2017 | 4 | 2017 |
| 206 Novel intermediate-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against human hepatocellular carcinoma L Caraballo-Galva, X Jiang, M Hussein, H Zhang, R Mao, P Brody, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Car-t cell compositions, methods of use thereof Y He, LDC GALVA, X Jiang US Patent App. 17/762,186, 2022 | | 2022 |
| Development of Novel Effective CAR-T Cell Therapy for Hepatocellular Carcinoma LDC Galva Augusta University, 2022 | | 2022 |
